Sugi Predict

Sugi Predict / Compounds / SCHEMBL30428234

SCHEMBL30428234

SCHEMBL30428234

CC(=O)N[C@H]1[C@H](O[C@@H]2[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@@H](O)[C@H](O)O[C@@H]2CO)O[C@H](CO)[C@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H]1O

nearest known ligand 0.72

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ MAG P20916 9/20 0.68
▸ SIGLEC7 Q9Y286 6/20 0.65
▸ SELP P16109 2/20 0.64
▸ SELL P14151 1/20 0.64
▸ SELE P16581 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29615736 0.97 SIGLEC7 (0.67) MAGSIGLEC7SELPSELLSELE
SCHEMBL18653452 0.97 SIGLEC7 (0.67) MAGSIGLEC7SELPSELLSELE
SCHEMBL29581405 0.97 MAG (0.69) MAGSIGLEC7SELPSELLSELE
SCHEMBL30122736 0.97 MAG (0.69) MAGSIGLEC7SELPSELLSELE
SCHEMBL29615820 0.96 SIGLEC7 (0.71) MAGSIGLEC7SELPSELLSELE
SCHEMBL30361171 0.96 SIGLEC7 (0.71) MAGSIGLEC7SELPSELLSELE
SCHEMBL29632930 0.95 SIGLEC7 (0.70) MAGSIGLEC7SELPSELLSELE
SCHEMBL30649376 0.95 SIGLEC7 (0.68) MAGSIGLEC7SELPSELLSELE
SCHEMBL31577597 0.95 SIGLEC7 (0.70) MAGSIGLEC7SELPSELLSELE
SCHEMBL30649886 0.95 SIGLEC7 (0.68) MAGSIGLEC7SELPSELLSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341411-B1 ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF ALECTOR LLC (US) 2025-06-11 — — EP disclosed
EP-3368575-B1 ANTI-SIGLEC-9 ANTIBODIES AND METHODS OF USE THEREOF ALECTOR LLC (US) 2025-05-07 — — EP disclosed
EP-4149625-A2 TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID AGENTS Viratides, LLC (US) 2023-03-22 — — EP disclosed
Send feedback